Tafenoquine May Improve Clinical Recovery Time for Patients With COVID-19
Researchers assessed the efficacy of tafenoquine for the treatment of mild to moderate COVID-19 infection.
COVID19 Vaccine
Does SARS-CoV-2 Vaccination Improve Post-Acute Sequelae of COVID-19?
How does COVID-19 vaccination affect individuals with post-acute sequelae of COVID-19 with respect to symptom control and immune response?
FDA Panel Supports Rollout of Tweaked Booster Shots From Moderna, Pfizer This Fall
A U.S. FDA recommended on Tuesday that updated COVID-19 booster shots be used this fall to protect against omicron and its highly contagious subvariants.
COVID-19 Antibodies Rapidly Decline 6 Months After Vaccination
Researchers assessed antibody responses among health care workers 9 months after COVID-19 vaccination.
Two Doses of BNT162b2 Moderately Effective for 5- to 11-Year-Olds
For children aged 5 to 11 years, two doses of BNT162b2 provide moderate protection against documented SARS-CoV-2 infection and symptomatic COVID-19.
Relative Risk for CVT Increased After AZD1222 COVID-19 Vaccine
The researchers identified 265,339 hospital contacts: 44, 21, and 35 percent for coronary artery disease, coagulation disorders, and cerebrovascular disease, respectively.
Vaccines Estimated to Have Prevented 19.8 Million COVID-19 Deaths
During the first year of COVID-19 vaccination, vaccines prevented 19.8 million deaths, using excess death as an estimate of the true extent of the pandemic.
FDA Advisors Back Moderna Shot for Older Children, Teens
The U.S. FDA’s vaccine advisory panel voted to recommend the agency approve the emergency use of Moderna’s COVID-19 vaccine in children aged 6 to 17.
Vaccine Effectiveness Against SARS-CoV-2 Infection Wanes Over Time
Vaccine effectiveness against SARS-CoV-2 infection and symptomatic COVID-19 wanes over time, but remains strong against severe COVID-19.
Ofatumumab for Multiple Sclerosis Does Not Increase COVID-19 Severity
Presenting at CMSC 2022, researchers evaluated COVID-19 outcomes among patients with MS who received treatment with ofatumumab.
- Loading...
Loading...
Next post in News
Loading... 
Loading...